Endogenous sex hormones and subsequent breast cancer in premenopausal women.
about
Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies.Endogenous sex steroids in premenopausal women and risk of breast cancer: the ORDET cohort.Androgen receptor expression and its relationship with clinicopathological parameters in an Iranian population with invasive breast carcinomaExercise lowers estrogen and progesterone levels in premenopausal women at high risk of breast cancer.Association of sulfotransferase SULT1A1 with breast cancer risk: a meta-analysis of case-control studies with subgroups of ethnic and menopausal statue.Diverse pathomechanisms leading to the breakdown of cellular estrogen surveillance and breast cancer development: new therapeutic strategies.Reduction in Ki-67 in benign breast tissue of high-risk women with the lignan secoisolariciresinol diglycosideProgestins and progesterone in hormone replacement therapy and the risk of breast cancer.Prospective case-control study of premenopausal serum estradiol and testosterone levels and breast cancer risk.Alcohol consumption in relation to plasma sex hormones, prolactin, and sex hormone-binding globulin in premenopausal womenThe bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?Effects of aerobic exercise on premenopausal sex hormone levels: results of the WISER study, a randomized clinical trial in healthy, sedentary, eumenorrheic women.Role of traditional and new biomarkers in breast carcinogenesis.Elevation of SIPL1 (SHARPIN) Increases Breast Cancer RiskCirculating sex steroids and breast cancer risk in premenopausal women.Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women.Can a single model explain both breast cancer and prostate cancer?Energy balance adiposity and breast cancer - energy restriction strategies for breast cancer prevention.Body size in relation to urinary estrogens and estrogen metabolites (EM) among premenopausal women during the luteal phase.Premenopausal serum androgens and breast cancer risk: a nested case-control study.Long-term weight change and breast cancer risk: the European prospective investigation into cancer and nutrition (EPIC).Adjuvant diet to improve hormonal and metabolic factors affecting breast cancer prognosis.Circulatory estrogen level protects against breast cancer in obese women.Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study IIEndogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk.Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart disease.Differential effects of various progestogens on metabolic risk factors for breast cancer.Effect of fenretinide and low-dose tamoxifen on insulin sensitivity in premenopausal women at high risk for breast cancer.Polycystic ovarian syndrome (PCOS), related symptoms/sequelae, and breast cancer risk in a population-based case-control study.Objective habitual physical activity and estradiol levels in obese Latina adolescentsA list of candidate cancer biomarkers for targeted proteomics.Reproducibility of fifteen urinary estrogens and estrogen metabolites over a 2- to 3-year period in premenopausal womenThe two major epidemics of the twenty-first century: obesity and cancer.Testosterone and risk of breast cancer: appraisal of existing evidence.Dose-response effects of aerobic exercise on estrogen among women at high risk for breast cancer: a randomized controlled trial.Effects of different progestogens on human breast tumor cell growth.Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status - results from the EPIC cohort.Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide.Opinion of the Scientific Panel on contaminants in the food chain (CONTAM) related to hormone residues in bovine meat and meat productsMiRNA-513a-5p Inhibits Progesterone Receptor Expression and Constitutes a Risk Factor For Breast Cancer: The ORDET Prospective Study.
P2860
Q30657567-E68D60ED-E3A1-47E2-A2AE-7251845B3DC7Q33739825-66D25C12-D6FB-4808-A7BD-F7B4D22AEC83Q33776271-0D7500F2-8843-4D51-9CD3-AE4F983B6318Q33976413-F461BBAF-A9DF-44E2-BF8F-D647BE591A8EQ34039337-1FED137E-0280-4FD3-AAE8-713C4C54757FQ34198265-C1108B8F-22EB-4D34-A9BA-DA5700F44D40Q34203765-3CC72E39-06CC-474C-A5D8-D73AB30B600DQ34420425-F3D4259E-19B4-4CDC-8F6E-E5D522E7D7D7Q34613562-BE4E6037-65EE-4249-B971-3C43DEEF13D0Q34642072-E4391E68-9255-45F2-B1CB-FC71657E4510Q34932849-E5B51371-A215-4501-8CC8-7C8CC24A9249Q35036641-CAB98A8E-8F4F-40DD-8810-B514FEFEE54BQ35572905-1402B82A-A184-464B-B713-F8C293E1AF14Q35625533-7AB2D783-9D6C-47B4-A86A-C49924B10E5EQ35659606-7350CB96-FC80-49A6-A64B-2411D666607DQ35729908-1B1CD6D6-87F6-4BD5-81D6-1B011AC5E678Q36054603-54B89EDD-EDFD-4F78-B60B-05046E1DB4C2Q36377241-F01252B3-44A3-4B2F-8ACB-F5EBC3581FF0Q36384976-DEB8F708-1B17-4862-8908-5CB14E9B8B76Q36393224-A1CA9645-8BC9-4D88-A0FA-3F6C4357EA6DQ36615256-55E6A83A-5F55-447C-9B29-1B547786E0D5Q36721734-0BECCBC2-428E-4601-9458-BF8DCA4A931DQ36795622-C3C81BA0-8154-432B-B234-6BB411945503Q36903340-6C92535B-14AB-4DCD-9EAB-DA9BB07DF62CQ36919219-E58BF9DA-1A80-40AD-8C09-D56B6878D93BQ36971981-43887760-9F19-4069-A3AA-7BA712025E1EQ36974417-AF187361-CC97-4981-B1C0-4A3CD121EB9EQ37008398-39DCE77E-8C75-4078-83B7-CAC2218E9F89Q37168300-0D834BC8-775A-42CE-9346-207F29A533C0Q37187751-CE9E4787-418B-4765-AC57-0974D51F41CDQ37277962-EEA990CF-1F9F-420D-ABD8-36587F5A4118Q37438330-ACCCE2CE-1ECA-4A03-97A2-72406A88702FQ37917654-4A222E5E-7AC7-4368-BB4E-2861B844E539Q38471436-163223B5-3799-4382-A6EC-E976F3E4CEF7Q38948954-5BE16050-01DA-44FC-A4EF-2C771D4EAFE4Q39581323-2296570F-0BA7-44F1-BCE3-34528B4136D9Q43408154-94009566-DE29-432F-BED2-115A92D8032CQ45370804-B876AC18-A5F5-478F-94F0-1473DBEA8B4EQ47144869-D28FA7D7-7391-41FD-95D1-5D0A40390C97Q47617574-FCF34557-B462-46EE-A432-EAD47B2779C8
P2860
Endogenous sex hormones and subsequent breast cancer in premenopausal women.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Endogenous sex hormones and subsequent breast cancer in premenopausal women.
@en
Endogenous sex hormones and subsequent breast cancer in premenopausal women.
@nl
type
label
Endogenous sex hormones and subsequent breast cancer in premenopausal women.
@en
Endogenous sex hormones and subsequent breast cancer in premenopausal women.
@nl
prefLabel
Endogenous sex hormones and subsequent breast cancer in premenopausal women.
@en
Endogenous sex hormones and subsequent breast cancer in premenopausal women.
@nl
P2093
P2860
P50
P356
P1476
Endogenous sex hormones and subsequent breast cancer in premenopausal women.
@en
P2093
Elisabetta Meneghini
Franco Berrino
Giorgio Secreto
Paola Muti
P2860
P304
P356
10.1002/IJC.20403
P577
2004-11-01T00:00:00Z